Best Medicines Coalition submission on high-cost drugs for rare diseases

The Best Medicines Coalition (BMC) is a national alliance of patient organizations, together representing millions of patients, with a shared goal of equitable, timely and consistent access to safe and effective medicines that improve patient outcomes.

On March 26, the BMC issued a submission to the Federal Government on its consultation on high-cost drugs for rare diseases. The CHS, which is a BMC member, has been an active contributor in drafting this submission.

CLICK HERE to access the submission.

Canadian Hemophilia Society
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.